Researchers at the Broad Institute of MIT and Harvard and the McGovern Institute for Brain Research at MIT have engineered changes to the revolutionary CRISPR-Cas9 genome editing system that significantly cut down on “off-target” editing errors. The refined technique addresses one of the major technical issues in the use of genome editing.
The CRISPR-Cas9 system works by making a precisely targeted modification in a cell’s DNA. The protein Cas9 alters the DNA at a location that is specified by a short RNA whose sequence matches that of the target site. While Cas9 is known to be highly efficient at cutting its target site, a major drawback of the system has been that, once inside a cell, it can bind to and cut additional sites that are not targeted. This has the potential to produce undesired edits that can alter gene expression or knock a gene out entirely, which might lead to the development of cancer or other problems. In a paper published today in Science, Feng Zhang and his colleagues report that changing three of the approximately 1,400 amino acids that make up the Cas9 enzyme from S. pyogenes dramatically reduced “off-target editing” to undetectable levels in the specific cases examined.
Zhang and his colleagues used knowledge about the structure of the Cas9 protein to decrease off-target cutting. DNA, which is negatively charged, binds to a groove in the Cas9 protein that is positively charged. Knowing the structure, the scientists were able to predict that replacing some of the positively charged amino acids with neutral ones would decrease the binding of “off target” sequences much more than “on target” sequences.
After experimenting with various possible changes, Zhang’s team found that mutations in three amino acids dramatically reduced “off-target” cuts. For the guide RNAs tested, “off-target” cutting was so low as to be undetectable.
The newly-engineered enzyme, which the team calls “enhanced” S. pyogenes Cas9, or eSpCas9, will be useful for genome editing applications that require a high level of specificity. The Zhang lab is immediately making the eSpCas9 enzyme available for researchers worldwide. The team believes the same charge-changing approach will work with other recently described RNA-guided DNA targeting enzymes, including Cpf1, C2C1, and C2C3, which Zhang and his collaborators reported on earlier this year.
The prospect of rapid and efficient genome editing raises many ethical and societal concerns, says Zhang, who is speaking this morning at the International Summit on Gene Editing in Washington, DC. “Many of the safety concerns are related to off-target effects,” he said. “We hope the development of eSpCas9 will help address some of those concerns, but we certainly don’t see this as a magic bullet. The field is advancing at a rapid pace, and there is still a lot to learn before we can consider applying this technology for clinical use.”
Read more: Broad, MIT scientists overcome key CRISPR-Cas9 genome editing hurdle
The Latest on: CRISPR-Cas9 genome editing
[google_news title=”” keyword=”CRISPR-Cas9 genome editing” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: CRISPR-Cas9 genome editing
- Unveiling the mysteries of cell division in embryos with timelapse photographyon April 24, 2024 at 7:40 am
The beginning of life is shrouded in mystery. While the intricate dynamics of mitosis are well-studied in the so-called somatic cells—the cells that have a specialized function, like skin and muscle ...
- AI-designed gene editing tools successfully modify human DNAon April 24, 2024 at 5:51 am
Medically, AI is helping us with everything from identifying abnormal heart rhythms before they happen to spotting skin cancer. But do we really need it to get involved with our genome? Protein-design ...
- GU Medical Center Distinguished Scientist Seminar Series Illuminates Uses of Gene Editing in Cancer Researchon April 23, 2024 at 5:00 pm
Genome editing is the process that allows scientists to change an organism’s DNA, including changing or cutting out sections of genetic code. Scientists adapted the CRISPR-Cas9 system, the most common ...
- Profluent combines LLMs and CRISPR for open-source AI gene editing projecton April 23, 2024 at 11:00 am
Profluent has staked a claim at the intersection of some of the buzziest terms in biopharma. | Profluent has staked a claim at the intersection of some of the buzziest terms in biopharma. The protein ...
- A small factor makes a big impact on genome editingon April 22, 2024 at 8:52 am
Through years of engineering gene-editing systems, researchers have developed a suite of tools that enable the modification of genomes in living cells, akin to "genome surgery." These tools, including ...
- Gene Editing Breakthrough: CRISPR-Cas9 Successfully Excises HIV from T-cells in Major Research Leapon April 9, 2024 at 8:06 pm
The CRISPR-Cas9 genome editing tool has demonstrated the capability to eradicate HIV viruses from cells cultured in laboratory settings, as per preliminary research slated for presentation at this ...
- CRISPR Gene Editing Eliminates HIV From Infected Cellson March 21, 2024 at 6:09 am
For the first time, the CRISPR-Cas9 gene editing system has been successfully ... After entering an immune cell, HIV's single-stranded RNA genome is reverse-transcribed into double-stranded ...
- CRISPR and Genome Editingon August 16, 2023 at 3:01 am
The genome editing tool CRISPR-Cas9 can eliminate HIV viruses from lab-cultured cells, according to not-yet peer-reviewed research to be presented at this year’s European Congress of Clinical ...
- CRISPR/Cas9-based genome editing for autologous CAR-T cell productionon July 22, 2021 at 9:45 am
In addition to random CAR insertion viral vectors also deliver partial viral sequences into the cell genome. These things together could disrupt essential gene functions and affect surrounding ...
- How to Realize the Immense Promise of Gene Editingon December 31, 2000 at 4:00 pm
Doudna applauded the 2023 FDA approval of a CRISPR-based gene editing therapy developed by Boston-based Vertex Pharmaceuticals and CRISPR Therapeutics to help those struggling with sickle cell disease ...
via Bing News